These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16717083)

  • 21. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
    Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA
    Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Off-label use of medications: innovative prescribing or risky business?
    Martin CM
    Consult Pharm; 2010 Dec; 25(12):806-10, 813-4. PubMed ID: 21172761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Out-of-hours demand for GP care and emergency services: patients' choices and referrals by general practitioners and ambulance services.
    Moll van Charante EP; van Steenwijk-Opdam PC; Bindels PJ
    BMC Fam Pract; 2007 Aug; 8():46. PubMed ID: 17672915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Returned medicines: waste or a wasted opportunity?
    Mackridge AJ; Marriott JF
    J Public Health (Oxf); 2007 Sep; 29(3):258-62. PubMed ID: 17579236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Off-label drug use in hospitalized children.
    Shah SS; Hall M; Goodman DM; Feuer P; Sharma V; Fargason C; Hyman D; Jenkins K; White ML; Levy FH; Levin JE; Bertoch D; Slonim AD
    Arch Pediatr Adolesc Med; 2007 Mar; 161(3):282-90. PubMed ID: 17339510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unlicensed and off label prescribing of drugs in general practice.
    McIntyre J; Conroy S; Avery A; Corns H; Choonara I
    Arch Dis Child; 2000 Dec; 83(6):498-501. PubMed ID: 11087285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reasons why medicines are returned to Swedish pharmacies unused.
    Ekedahl AB
    Pharm World Sci; 2006 Dec; 28(6):352-8. PubMed ID: 17221141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unlicensed and off-label drug use in a Swiss paediatric university hospital.
    Di Paolo ER; Stoetter H; Cotting J; Frey P; Gehri M; Beck-Popovic M; Tolsa JF; Fanconi S; Pannatier A
    Swiss Med Wkly; 2006 Apr; 136(13-14):218-22. PubMed ID: 16633971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Licensing and labelling of drugs in a paediatric oncology ward.
    van den Berg H; Tak N
    Br J Clin Pharmacol; 2011 Sep; 72(3):474-81. PubMed ID: 21453298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in heart failure medications in patients hospitalised and discharged.
    Scherer M; Sobek C; Wetzel D; Koschack J; Kochen MM
    BMC Fam Pract; 2006 Nov; 7():69. PubMed ID: 17123439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Off-label prescribing].
    Blondon K; Desmeules J; Vogt-Ferrier N; Besson M; Kondo-Oestreicher M; Dayer P
    Rev Med Suisse; 2008 Jul; 4(165):1661-5. PubMed ID: 18767292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Off-label prescribing of medications for children.
    Monestime-Williams N; Dickerson LM; Basco WT
    J S C Med Assoc; 2007 Jun; 103(5):130-3. PubMed ID: 18333578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in availability of paediatric medicines in Australia between 1998 and 2002.
    Chui J; Tordoff J; Reith D
    Br J Clin Pharmacol; 2005 Jun; 59(6):736-42. PubMed ID: 15948941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.
    Roughead E; Pratt N; Peck R; Gilbert A
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):797-803. PubMed ID: 17476702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Access to medications in the community by patients in a palliative setting. A systems analysis.
    Lucey M; McQuillan R; MacCallion A; Corrigan M; Flynn J; Connaire K
    Palliat Med; 2008 Mar; 22(2):185-9. PubMed ID: 18372383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients either contacting a general practice cooperative or accident and emergency department out of hours: a comparison.
    Giesen P; Franssen E; Mokkink H; van den Bosch W; van Vugt A; Grol R
    Emerg Med J; 2006 Sep; 23(9):731-4. PubMed ID: 16921097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diurnal variation of prescribing pattern of primary care doctors in Bahrain.
    Damanhori AH; Al Khaja KA; Sequeira RP; Al-Ansari TM
    J Eval Clin Pract; 2007 Feb; 13(1):25-30. PubMed ID: 17286720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children.
    Conroy S; Newman C; Gudka S
    Ann Oncol; 2003 Jan; 14(1):42-7. PubMed ID: 12488291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.